CanBas Co.,Ltd.
4575 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 沼津市大手町二丁目２番１号
- Website:
- https://www.canbas.co.jp/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
CanBas Co., Ltd. is an innovative bioventure company based in Japan, specializing in the research and development of novel cancer therapies. With a commitment to advancing cancer treatment, CanBas focuses on creating effective chemotherapeutic agents aimed at improving patient outcomes. The company emphasizes transparency and engagement, regularly sharing insights through management blogs that provide updates beyond standard disclosures. CanBas is dedicated to its mission of pioneering breakthroughs in cancer medicine, guided by a strong management team and a robust corporate ethos.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-02-13 07:55 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2025-02-13 07:54 |
Interim Report
半期報告書－第26期(2024/07/01－2025/06/30)
|
Japanese | 160.4 KB | |
| 2024-09-30 08:04 |
Inside Information Statement
臨時報告書
|
Japanese | 22.7 KB | |
| 2024-09-27 08:21 |
Internal Control over Financial Reporting
内部統制報告書－第25期(2023/07/01－2024/06/30)
|
Japanese | 21.7 KB | |
| 2024-09-27 08:21 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2024-09-27 08:20 |
Annual Report
有価証券報告書－第25期(2023/07/01－2024/06/30)
|
Japanese | 637.2 KB | |
| 2024-05-10 08:16 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2024-05-10 08:16 |
Quarterly Report
四半期報告書－第25期第3四半期(2024/01/01－2024/03/31)
|
Japanese | 134.6 KB | |
| 2024-02-09 08:13 |
Regulatory News Service
確認書
|
Japanese | 8.0 KB | |
| 2024-02-09 08:12 |
Quarterly Report
四半期報告書－第25期第2四半期(2023/10/01－2023/12/31)
|
Japanese | 163.0 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Nippon Shinyaku Co.,Ltd. | Japan | 4516 | |
|
Noile-Immune Biotech Inc. | Japan | 4893 | |
|
Novartis AG | Switzerland | NOVN | |
|
Nur Ink Innovations Ltd. | Israel | NURI | |
|
Nxera Pharma Co., Ltd. | Japan | 4565 | |
|
ObsEva SA | Switzerland | OBSN | |
|
ODI Pharma AB | Sweden | ODI | |
|
Oncolys BioPharma Inc. | Japan | 4588 | |
|
OncoTherapy Science, Inc. | Japan | 4564 | |
|
OncoZenge AB | Sweden | ONCOZ |